EUVIMEDOpdag EUVIMED
Crossref

Licochalcone A alleviates abnormal glucolipid metabolism and restores energy homeostasis in diet‐induced diabetic mice

Doudou Wang, Lin Yang, Wenwen Ding, Ziyi Chen, Xiaoxue Yang, Yu Jiang, Ying Liu iD

Phytotherapy Research · 2024-01 · 38 (1) · 196-213

DOI: 10.1002/ptr.8044 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2023-10-18. Written by Doudou Wang and 6 co-authors. Institution: School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China. Major MEDLINE topics: Chalcones, Diabetes Mellitus, Experimental, Insulin Resistance. Cited 16 times so far (Crossref); 87 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Licochalcone A (LCA) is a bioactive chalcone compound identified in licorice. This study aimed to investigate the effects of LCA on glucolipid metabolism and energy homeostasis, as well as the underlying mechanisms. Blood glucose levels, oral glucose tolerance, serum parameters, and histopathology were examined in high‐fat‐high‐glucose diet (HFD)‐induced diabetic mice, with metformin as a positive control. Additionally, changes in key markers related to glucolipid metabolism and mitochondrial function were analyzed to comprehensively assess LCA's effects on metabolism. The results showed that LCA alleviated metabolic abnormalities in HFD‐induced diabetic mice, which were manifested by suppression of lipogenesis, promotion of lipolysis, reduction of hepatic steatosis, increase in hepatic glycogenesis, and decrease in gluconeogenesis. In addition, LCA restored energy homeostasis by promoting mitochondrial biogenesis, enhancing mitophagy, and reducing adenosine triphosphate production. Mechanistically, the metabolic benefits of LCA were associated with the downregulation of mammalian target of rapamycin complex 1 and activation of adenosine monophosphate‐activated protein kinase, the two central regulators of metabolism. This study demonstrates that LCA can alleviate abnormal glucolipid metabolism and restore energy balance in diet‐induced diabetic mice, highlighting its therapeutical potential for the treatment of diabetes.

Subjects

MeSH terms (MEDLINE)

ChalconesDiabetes Mellitus, ExperimentalInsulin ResistanceMiceAnimalsDiet, High-FatHomeostasisLiverMice, Inbred C57BLAMP-Activated Protein KinasesEnergy MetabolismMammals

Author keywords

AMPKlicochalcone AmTORC1mitochondrial functionstype 2 diabetes mellitus

Substances

licochalcone AChalconesAMP-Activated Protein Kinases

Authors and institutions

  • School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
  • Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID profiles: Ying Liu

Cite

APA

Wang, D., Yang, L., Ding, W., Chen, Z., Yang, X., Jiang, Y., & Liu, Y. (2024). Licochalcone A alleviates abnormal glucolipid metabolism and restores energy homeostasis in diet‐induced diabetic mice. Phytotherapy Research, 38(1), 196-213. https://doi.org/10.1002/ptr.8044

Vancouver

Wang D, Yang L, Ding W, Chen Z, Yang X, Jiang Y, et al. Licochalcone A alleviates abnormal glucolipid metabolism and restores energy homeostasis in diet‐induced diabetic mice. Phytotherapy Research. 2024;38(1):196-213. doi:10.1002/ptr.8044

BibTeX
@article{Wang2024,
  author = {Wang, Doudou and Yang, Lin and Ding, Wenwen and Chen, Ziyi and Yang, Xiaoxue and Jiang, Yu and Liu, Ying},
  title = {Licochalcone A alleviates abnormal glucolipid metabolism and restores energy homeostasis in diet‐induced diabetic mice},
  journal = {Phytotherapy Research},
  year = {2024},
  volume = {38},
  number = {1},
  pages = {196--213},
  doi = {10.1002/ptr.8044}
}
Start for free →